Company: SMNR
Filing Date: 2025-08-22
Form Type: DEFA14A
Source: 0001213900-25-079507
Chunk: 37

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-22
Form: DEFA14A
Chunk 37
---
 in its sole discretion by providing Semnur with prior written notice thereof:

(a) Semnur shall have duly executed and delivered to such Buyer (i) each of the Semnur Transaction Documents and (ii) the Common Shares (allocated in such amounts as such Buyer shall request), being purchased by such Buyer at the Closing pursuant to this Agreement.

(b) Denali (as New Semnur) shall have duly executed and delivered to such Buyer each of the Denali Transaction Documents.

(c) The representations and warranties of each of Semnur and Denali shall be true and correct in all material respects as of the date when made and as of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date which shall be true and correct in all material respects as of such specified date) and each of Semnur and Denali shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing Date.

(d) Each of Semnur and Denali shall have obtained all stockholder, governmental, regulatory or other third party consents and approvals necessary for the completion of the Business Combination.

(e) All conditions precedent to the closing of the Business Combination contained in the Merger Agreement shall have been satisfied or waived.

(f) [Reserved].

(g) All lock-up provisions and other restrictions on transfer applicable to the equity securities of Denali held by Denali Capital Global Investments LLC (the “ Sponsor”) pursuant to any agreements or arrangements in effect prior to the execution of this Agreement, including that certain Letter Agreement, dated as of April 6, 2022, by and among Denali Capital Acquisition Corp., Sponsor and certain security holders named therein and the other agreements disclosed in the SEC Documents, shall remain in full force and effect in accordance with their terms immediately following the Closing, and neither Denali nor the Sponsor shall have taken any action to waive, amend, terminate, or otherwise release the Sponsor from such provisions or restrictions.

<div align='center'>21</div>

8. TERMINATION. In the event that the Closing shall not have occurred with respect to a Buyer on or before December 31, 2025 due to Semnur’s, Denali’s or such Buyer’s failure to satisfy the conditions set forth in Sections 6 and 7 above (and the nonbreaching party’s failure to waive such unsatisfied condition(s)),